Stay updated on AK104 in NSCLC Phase II Clinical Trial

Sign up to get notified when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 in NSCLC Phase II Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:16:57.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    An entry for revision v3.3.2 was added to the history. The previously listed revision v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:15:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The lapse in government funding notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-18T07:01:23.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The version history shows updates to recruitment status (and study status) for the AK104 trial in advanced non-small cell lung cancer on 2022-03-24 and 2025-03-10, with the latest entry indicating the current recruitment status.
    Difference
    0.1%
    Check dated 2025-11-03T21:06:47.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 accompanied by a government-operating-status notice; replaces v3.1.0.
    Difference
    13%
    Check dated 2025-10-06T05:34:57.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:05:37.000Z thumbnail image

Stay in the know with updates to AK104 in NSCLC Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.